Enfermedad Inflamatoria Pélvicaa propósito de un caso

  1. Manuel Flores Sáenz 1
  2. Soledad Oñate Tejada 1
  1. 1 Universidad de Alcalá
    info

    Universidad de Alcalá

    Alcalá de Henares, España

    ROR https://ror.org/04pmn0e78

Aldizkaria:
RIECS: Revista de Investigación y Educación en Ciencias de la Salud

ISSN: 2530-2787

Argitalpen urtea: 2023

Alea: 8

Zenbakia: 2

Orrialdeak: 43-47

Mota: Artikulua

DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: RIECS: Revista de Investigación y Educación en Ciencias de la Salud

Laburpena

We present the case of a 35-year-old female patient who attended the emergency department of the Hospital Universitario Príncipe de Asturias (HUPA) due to continuous, stabbing pain in the right iliac fossa for 48 hours, which did not subside with analgesiaat home. She reported an increase in vaginal discharge of watery consistency, bloody appearance and dyspareunia for 3 months. She currently refers to a stable partner. The patient has had a levonorgestrel intrauterine device (IUD) since March 2018 with the following gestational formula (G1A0P1). Physical examination revealed a painful cervix on mobilisation. Uterus in anteroversion and regular. The right adnexa was painful on palpation. On the other hand, the transvaginal ultrasound showed a 5-centimetre right adnexal image compatible with a pyosalpinx. The patient was diagnosed with Pelvic Inflammatory Disease grade III (Monif Scale) and was admitted on suspicion of tubo-ovarian abscess. During admission, a culture of vaginal and endocervical exudate, haemogram, biochemistry and blood culture were requested and her evolution was monitored. Antibiotic therapy was prescribed for the patient and her partner, and the IUD was removed after the start of the treatment. The aim of this case is to highlight the importance of early diagnosis in the prevention of complications such as infertility, as well as to review the clinical management algorithm proposed by HUPA.

Erreferentzia bibliografikoak

  • Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2015. Pelvic Inflammatory Disease (PID). MMWR Recomm Rep. 2015;64(RR-03):1-137.
  • Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19(4):185-192. doi:10.1097/00007435-199207000-00001.
  • Peláez-Mendoza J. Enfermedad inflamatoria pélvica y adolescencia. Rev Cubana de Obstet y Ginecol. 2012;38(1):64-79.
  • Peipert JF, Lapane KL, Allsworth JE, et al. Bacterial vaginosis, trichomoniasis, and vaginal douching: risk factors for pelvic inflammatory disease. Sex Transm Dis. 2005;32(12):765-770.
  • Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis. 2008;21(1):65-69.
  • Sociedad Española de Ginecología y Obstetricia (SEGO). Guía de práctica clínica sobre enfermedad inflamatoria pélvica. Actualización 2020. Disponible en: https://www.sego.es/wpcontent/uploads/2020/10/Enfermedad-inflamatoria-pelvica-EOI_2020.pdf.
  • Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137.
  • Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med. 2015 Mar 26;372(21):2039-48.
  • Soper DE. Pelvic inflammatory disease. Obstet Gynecol. 2010 Oct;116(4):1007-17.
  • Shreeves K, Turocy R, Wechter ME, et al. Pelvic inflammatory disease: improving awareness, prevention, and treatment. Infect Drug Resist. 2016;9:191-197.
Datuen iturria: Dialnet